I3T collage 2023

Immunity, Inflammation, Infection, and Transplantation (I3T) Research Theme

Investigator Spotlights

Dr. Lili Yang

Dr. Lili Yang

Engineered killer T cells could provide long-lasting immunity against cancer. UCLA researchers use stem cells to engineer cells that attack human tumors in mice.
Learn More →

Learn & Discover

Serving Pediatric Patients

How do we serve pediatric patients with rare immune diseases? Manish Butte, MD, PhD, a pediatric immunologist at UCLA Health talks about bringing advanced laboratory capabilities to kids with rare immune diseases
Learn More →

Donor Spotlight

Connie Frank and Evan Thompson

A Generous Contribution

To establish the Connie Frank and Evan Thompson Program for Restorative Transplantation Research, under the direction of Dr. Kodi Azari (FEL ’04) in the Department of Surgery.
Learn More →


I3T Seminar Series

The I3T Seminar Series 2022-23 is planning to be back in person this year with an outstanding lineup of speakers. We have already confirmed dates with the speakers below, and we will be sending out the lineup to all our members shortly. Do not hesitate to contact us at I3T@mednet.ucla.edu for any questions. 

View Seminar Series


Upcoming Seminars


Head shot of Peter D. Crompton, M.D., M.P.H.

Speaker: Peter D. Crompton, M.D., M.P.H
Title: Senior Investigator Chief, Malaria Infection Biology and Immunity Section
Institution: National Institutes of Health
Organizing in partnership with: CTSI
Date: Wednesday, May 24, 2023
Location: In-person NRB Auditorium 132 & Zoom






Speakers: Christopher Luther (Kohn’s Lab) & Meagan Jenkins (Reed’s Lab) 
Institution: UCLA 
Date: Tuesday, May 30, 2023
Location: In-person CHS 53-105
Additional Information: Research In Progress




Head Shot of Megan Levings, Ph.D.

Speaker: Megan Levings, Ph.D.
Title: Professor
Institution: University of British Columbia
Date: Tuesday, June 13, 2023
Location: In-person CHS 53-105


"Once we fully understand the rules of the immune system, then we can harness the immune system therapeutically to cure disease.”

Gay M. Crooks, MD, Director, I3T Research Theme